ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,921,000 | +40.3% | 68,532 | -3.2% | 0.07% | +41.2% |
| Q2 2021 | $8,499,000 | +37.8% | 70,828 | +40.3% | 0.05% | +37.8% |
| Q1 2021 | $6,167,000 | +39.1% | 50,497 | +41.9% | 0.04% | +32.1% |
| Q4 2020 | $4,435,000 | +136.0% | 35,588 | +107.1% | 0.03% | +100.0% |
| Q3 2020 | $1,879,000 | +74.1% | 17,184 | +68.2% | 0.01% | +75.0% |
| Q2 2020 | $1,079,000 | -8.6% | 10,214 | -14.0% | 0.01% | -27.3% |
| Q1 2020 | $1,181,000 | -34.9% | 11,872 | -43.5% | 0.01% | -21.4% |
| Q4 2019 | $1,815,000 | +76.7% | 21,031 | -14.1% | 0.01% | +75.0% |
| Q3 2019 | $1,027,000 | -3.8% | 24,484 | -4.3% | 0.01% | -11.1% |
| Q2 2019 | $1,068,000 | -14.6% | 25,579 | -8.5% | 0.01% | -10.0% |
| Q1 2019 | $1,251,000 | +29.8% | 27,969 | +14.8% | 0.01% | +25.0% |
| Q4 2018 | $964,000 | -21.0% | 24,369 | +1.2% | 0.01% | -20.0% |
| Q3 2018 | $1,220,000 | – | 24,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |